Novo Nordisk names Vikrant Shrotriya as Managing Director for India business
Vikrant Shrotriya was recently working in the GCC (Gulf Cooperation Council) countries wherein he was Vice-President for company's GCC business and Corporate Vice President for Saudi Arabia, Novo Nordisk added.
New Delhi: Global healthcare firm Novo Nordisk on Thursday said it has appointed Vikrant Shrotriya as Managing Director and Corporate Vice President for India business.
He returns to India after 13 years with an overall career spanning over 20 years in the healthcare industry in India and internationally, Novo Nordisk said in a statement.
Vikrant was recently working in the GCC (Gulf Cooperation Council) countries wherein he was Vice-President for company's GCC business and Corporate Vice President for Saudi Arabia, it added.
Read Also: Novo Nordisk wins USFDA nod for oral diabetes drug Rybelsus
"India is an important market for us, and our focus is on enhancing healthcare through awareness and education. We will continue to work on improving access to quality care by working closely with the relevant stakeholders," Shrotriya said.
Novo Nordisk insulins have been in presence in India since 1935 and the Indian affiliate was operationalised in 1994.
Read Also: Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd